337 related articles for article (PubMed ID: 25381809)
1. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
2. Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis.
Prado MB; Adiao KJB
Can J Diabetes; 2024 Jun; 48(4):233-243.e10. PubMed ID: 38295879
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials.
Ran GL; Li YP; Lu LC; Lan SH
J Diabetes Complications; 2024 Feb; 38(2):108691. PubMed ID: 38330524
[TBL] [Abstract][Full Text] [Related]
4. Painful diabetic neuropathy: advantage of novel drugs over old drugs?
Ziegler D
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S414-9. PubMed ID: 19875591
[No Abstract] [Full Text] [Related]
5. Effects of baicalin capsules combined with α-lipoic acid on nerve conduction velocity, oxidative stress and inflammatory injury in patients with diabetic peripheral neuropathy.
Tang C; Han R; Wu J; Fang F
Am J Transl Res; 2021; 13(4):2774-2783. PubMed ID: 34017440
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant strategies in the management of diabetic neuropathy.
Oyenihi AB; Ayeleso AO; Mukwevho E; Masola B
Biomed Res Int; 2015; 2015():515042. PubMed ID: 25821809
[TBL] [Abstract][Full Text] [Related]
7. Review of Diabetic Polyneuropathy: Pathogenesis, Diagnosis and Management According to the Consensus of Egyptian Experts.
Amara F; Hafez S; Orabi A; El Etriby A; Abdel Rahim AA; Zakaria E; Koura F; Talaat FM; Gawish H; Attia I; Abdel Aziz MF; El Hefnawy MHMF; Kamar M; Halawa MR; El-Sayed MS; El Kafrawy NA; Khalil SHA; Assaad SN
Curr Diabetes Rev; 2019; 15(4):340-345. PubMed ID: 30813879
[TBL] [Abstract][Full Text] [Related]
8. Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review.
Goh JK; Koh L
Diabetol Int; 2023 Jul; 14(3):224-242. PubMed ID: 37397902
[TBL] [Abstract][Full Text] [Related]
9. Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials.
Mijnhout GS; Kollen BJ; Alkhalaf A; Kleefstra N; Bilo HJ
Int J Endocrinol; 2012; 2012():456279. PubMed ID: 22331979
[TBL] [Abstract][Full Text] [Related]
10. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.
Gomes MB; Negrato CA
Diabetol Metab Syndr; 2014; 6(1):80. PubMed ID: 25104975
[TBL] [Abstract][Full Text] [Related]
11. siRNA Treatments for Diabetic Neuropathy: Obstacles and Delivery Techniques.
Akhtar MS; Mohsin N; Zahak A; Ahmed KAAA; Alhazmi Y; Taleuzzaman M
Curr Mol Med; 2024 Jun; ():. PubMed ID: 38918983
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.
Rochette L; Ghibu S; Muresan A; Vergely C
Can J Physiol Pharmacol; 2015 Dec; 93(12):1021-7. PubMed ID: 26406389
[TBL] [Abstract][Full Text] [Related]
13. Treatment of painful diabetic neuropathy.
Javed S; Petropoulos IN; Alam U; Malik RA
Ther Adv Chronic Dis; 2015 Jan; 6(1):15-28. PubMed ID: 25553239
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Lipoic Acid for Treatment of Diabetic Peripheral Neuropathy.
Bartkoski S; Day M
Am Fam Physician; 2016 May; 93(9):786. PubMed ID: 27175957
[No Abstract] [Full Text] [Related]
15. Treatment with α-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading.
Garcia-Alcala H; Santos Vichido CI; Islas Macedo S; Genestier-Tamborero CN; Minutti-Palacios M; Hirales Tamez O; García C; Ziegler D
J Diabetes Res; 2015; 2015():189857. PubMed ID: 26345602
[TBL] [Abstract][Full Text] [Related]
16. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Ziegler D; Gries FA
Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
[TBL] [Abstract][Full Text] [Related]
17. Burning through the pain: treatments for diabetic neuropathy.
Javed S; Alam U; Malik RA
Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288
[TBL] [Abstract][Full Text] [Related]
18. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of treatments for diabetic peripheral neuropathy.
Çakici N; Fakkel TM; van Neck JW; Verhagen AP; Coert JH
Diabet Med; 2016 Nov; 33(11):1466-1476. PubMed ID: 26822889
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
